PTX3 could recruit and combine with Factor H to inhibit tumor‐related inflammation by regulating complement‐dependent tumor‐related inflammation, thus acting as an exogenous tumor suppressor to inhibit tumor‐related inflammation.14, 15. The gene discussed is PTX3; the disease is neoplasm.